A. Levey, J. Beto, and B. Coronado, Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease, American Journal of Kidney Diseases, vol.32, issue.5, pp.853-906, 1998.
DOI : 10.1016/S0272-6386(98)70145-3

R. Foley, P. Parfrey, and M. Sarnak, Clinical epidemiology of cardiovascular disease in chronic renal disease, American Journal of Kidney Diseases, vol.32, issue.5, pp.112-119, 1998.
DOI : 10.1053/ajkd.1998.v32.pm9820470

A. Cheung, M. Sarnak, and G. Yan, Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients, Kidney International, vol.58, issue.1, pp.353-362, 2000.
DOI : 10.1046/j.1523-1755.2000.00173.x

A. Kato, T. Takita, and Y. Maruyama, Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients, Kidney International, vol.64, issue.4, pp.1472-1479, 2003.
DOI : 10.1046/j.1523-1755.2003.00205.x

G. London, A. Guerin, and S. Marchais, Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrology Dialysis Transplantation, vol.18, issue.9, pp.1731-1740, 2003.
DOI : 10.1093/ndt/gfg414

G. Block, T. Hulbert-shearon, N. Levin, and F. Port, Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study, American Journal of Kidney Diseases, vol.31, issue.4, pp.607-6171226, 1998.
DOI : 10.1053/ajkd.1998.v31.pm9531176

Y. Tintut, F. Parhami, and K. Bostrom, cAMP Stimulates Osteoblast-like Differentiation of Calcifying Vascular Cells. POTENTIAL SIGNALING PATHWAY FOR VASCULAR CALCIFICATION, Journal of Biological Chemistry, vol.273, issue.13, pp.7547-7553, 1998.
DOI : 10.1074/jbc.273.13.7547

Y. Tintut and L. Demer, Recent advances in multifactorial regulation of vascular calcification, Current Opinion in Lipidology, vol.12, issue.5, pp.555-560, 2001.
DOI : 10.1097/00041433-200110000-00012

P. Collin-osdoby, Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin, Circulation Research, vol.95, issue.11, pp.1046-1057, 2004.
DOI : 10.1161/01.RES.0000149165.99974.12

W. Simonet, D. Lacey, and C. Dunstan, Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density, Cell, vol.89, issue.2, pp.309-319, 1997.
DOI : 10.1016/S0092-8674(00)80209-3

D. Lacey, E. Timms, and H. Tan, Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation, Cell, vol.93, issue.2, pp.165-176, 1998.
DOI : 10.1016/S0092-8674(00)81569-X

M. Schoppet, A. Sattler, and J. Schaefer, Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1024-1028, 2003.
DOI : 10.1210/jc.2002-020775

S. Kiechl, G. Schett, and G. Wenning, Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease, Circulation, vol.109, issue.18, pp.2175-2180, 2004.
DOI : 10.1161/01.CIR.0000127957.43874.BB

M. Schoppet, J. Schaefer, and L. Hofbauer, Acknowledgments * Response, Circulation, vol.107, issue.11, pp.76-76, 2003.
DOI : 10.1161/01.CIR.0000060815.25798.02

L. Garred, D. Barichello, and B. Digiuseppe, Simple Kt/V Formulas Based on Urea Mass Balance Theory, ASAIO Journal, vol.40, issue.4, pp.997-1004, 1994.
DOI : 10.1097/00002480-199410000-00017

A. Benetos, M. Safar, and A. Rudnichi, Pulse Pressure : A Predictor of Long-term Cardiovascular Mortality in a French Male Population, Hypertension, vol.30, issue.6, pp.1410-1415, 1997.
DOI : 10.1161/01.HYP.30.6.1410

A. Avignon, A. Sultan, and C. Piot, Osteoprotegerin Is Associated With Silent Coronary Artery Disease in High-Risk but Asymptomatic Type 2 Diabetic Patients, Diabetes Care, vol.28, issue.9, pp.2176-2180, 2005.
DOI : 10.2337/diacare.28.9.2176

L. Maïmoun, I. Couret, and D. Mariano-goulart, Changes in Osteoprotegerin/RANKL System, Bone Mineral Density, and Bone Biochemicals Markers in Patients with Recent Spinal Cord Injury, Calcified Tissue International, vol.27, issue.6, pp.404-411, 2005.
DOI : 10.1007/s00223-004-0048-6

P. Klassen, E. Lowrie, and D. Reddan, Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis, JAMA, vol.287, issue.12, pp.1548-1555, 2002.
DOI : 10.1001/jama.287.12.1548

M. Tozawa, K. Iseki, C. Iseki, and S. Takishita, Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis, Kidney International, vol.61, issue.2, pp.717-726, 2002.
DOI : 10.1046/j.1523-1755.2002.00173.x

J. Blacher, A. Guerin, and B. Pannier, Impact of Aortic Stiffness on Survival in End-Stage Renal Disease, Circulation, vol.99, issue.18, pp.2434-2439, 1999.
DOI : 10.1161/01.CIR.99.18.2434

W. Goodman, J. Goldin, and B. Kuizon, Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis, New England Journal of Medicine, vol.342, issue.20, pp.1478-1483, 2000.
DOI : 10.1056/NEJM200005183422003

P. Raggi, A. Boulay, and S. Chasan-taber, Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?, ACC Current Journal Review, vol.11, issue.4, pp.695-701, 2002.
DOI : 10.1016/S1062-1458(02)00700-6

A. Guerin, G. London, S. Marchais, and F. Metivier, Arterial stiffening and vascular calcifications in end-stage renal disease, Nephrology Dialysis Transplantation, vol.15, issue.7, pp.1014-1021, 2000.
DOI : 10.1093/ndt/15.7.1014

M. Cozzolino, A. Dusso, and E. Slatopolsky, Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure, J Am Soc Nephrol, vol.12, issue.11, pp.2511-2516, 2001.

S. Ganesh, A. Stack, and N. Levin, Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients, J Am Soc Nephrol, vol.12, issue.10, pp.2131-2138, 2001.

G. Block, P. Klassen, and J. Lazarus, Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis, Journal of the American Society of Nephrology, vol.15, issue.8, pp.2208-2218, 2004.
DOI : 10.1097/01.ASN.0000133041.27682.A2

M. Avram, N. Mittman, M. Myint, and P. Fein, Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation, American Journal of Kidney Diseases, vol.38, issue.6, pp.1351-1357, 2001.
DOI : 10.1053/ajkd.2001.29254

M. Marco, L. Craver, and A. Betriu, Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population, Kidney International, vol.63, issue.85, pp.111-114, 2003.
DOI : 10.1046/j.1523-1755.63.s85.26.x

G. London, C. Marty, and S. Marchais, Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease, Journal of the American Society of Nephrology, vol.15, issue.7, pp.1943-1951, 2004.
DOI : 10.1097/01.ASN.0000129337.50739.48

L. Stevens, O. Djurdjev, and S. Cardew, Calcium, Phosphate, and Parathyroid Hormone Levels in Combination and as a Function of Dialysis Duration Predict Mortality: Evidence for the Complexity of the Association between Mineral Metabolism and Outcomes, Journal of the American Society of Nephrology, vol.15, issue.3, pp.770-779, 2004.
DOI : 10.1097/01.ASN.0000113243.24155.2F

S. Moe, O. Neill, K. Duan, and D. , Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins, Kidney International, vol.61, issue.2, pp.638-647, 2002.
DOI : 10.1046/j.1523-1755.2002.00170.x

T. Doherty, K. Asotra, and L. Fitzpatrick, Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads, Proceedings of the National Academy of Sciences, vol.360, issue.6406, pp.11201-11206, 2003.
DOI : 10.1038/360741a0

T. Doherty, L. Fitzpatrick, and D. Inoue, Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification, Endocrine Reviews, vol.25, issue.4, pp.629-672, 2004.
DOI : 10.1210/er.2003-0015

C. Dhore, J. Cleutjens, and E. Lutgens, Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.12, pp.1998-2003, 2001.
DOI : 10.1161/hq1201.100229

K. Hruska, G. Saab, and L. Chaudhary, Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy, Seminars in Nephrology, vol.24, issue.1, pp.25-38, 2004.
DOI : 10.1053/j.semnephrol.2003.08.010

M. Schoppet, K. Preissner, and L. Hofbauer, RANK Ligand and Osteoprotegerin: Paracrine Regulators of Bone Metabolism and Vascular Function, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.4, pp.549-553, 2002.
DOI : 10.1161/01.ATV.0000012303.37971.DA

W. Browner, L. Lui, and S. Cummings, Associations of Serum Osteoprotegerin Levels with Diabetes, Stroke, Bone Density, Fractures, and Mortality in Elderly Women, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.2, pp.631-637, 2001.
DOI : 10.1210/jc.86.2.631

J. Kazama, H. Kato, and T. Sato, Circulating osteoprotegerin is not removed through haemodialysis membrane, Nephrology Dialysis Transplantation, vol.17, issue.10, pp.1860-1861, 2002.
DOI : 10.1093/ndt/17.10.1860
URL : http://ndt.oxfordjournals.org/cgi/content/short/17/10/1860

K. Nitta, T. Akiba, and K. Uchida, Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients, Nephrology Dialysis Transplantation, vol.19, issue.7, pp.1886-1889, 2004.
DOI : 10.1093/ndt/gfh263

D. Barreto, F. Barreto, and A. Carvalho, Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors, Kidney International, vol.67, issue.4, pp.1576-1582, 2005.
DOI : 10.1111/j.1523-1755.2005.00239.x

K. Nitta, T. Akiba, and K. Uchida, The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis, American Journal of Kidney Diseases, vol.42, issue.2, pp.303-309, 2003.
DOI : 10.1016/S0272-6386(03)00655-3

N. Bucay, I. Sarosi, and C. Dunstan, osteoprotegerin-deficient mice develop early onset osteoporosis and arterial??calcification, Genes & Development, vol.12, issue.9, pp.1260-1268, 1998.
DOI : 10.1101/gad.12.9.1260
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC316769

S. Moe, M. Reslerova, and M. Ketteler, Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD), Kidney International, vol.67, issue.6, pp.2295-2304, 2005.
DOI : 10.1111/j.1523-1755.2005.00333.x

M. Ketteler, P. Bongartz, and R. Westenfeld, Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study, The Lancet, vol.361, issue.9360, pp.827-833, 2003.
DOI : 10.1016/S0140-6736(03)12710-9